| 1 |
Foster N, Cunnama L, McCarthy K, Ramma L, Siapka M, Sinanovic E, Churchyard G, Fielding K, Grant AD, Cleary S. Strengthening health systems to improve the value of tuberculosis diagnostics in South Africa: A cost and cost-effectiveness analysis. PLoS One 2021;16:e0251547. [PMID: 33989317 DOI: 10.1371/journal.pone.0251547] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 2 |
Seminario A, Anibarro L, Sabriá J, García-Clemente MM, Sánchez-Montalván A, Medina JF, Mir I, Penas A, Caminero JA, Pérez GJ, Altet N, Domínguez Á, Jiménez-Fuentes MÁ, Quirós S, Tabernero EM, Souza-Galvão ML, Sáez A, Caylà JA, García-García JM, Rodrigo T; Working Group of the Integrated Tuberculosis Research Program (PII-TB) of the Spanish Society of Pulmonology and Thoracic Surgery (SEPAR). Study of the Diagnostic Delay of Tuberculosis in Spain. Arch Bronconeumol 2021;57:440-2. [PMID: 34088404 DOI: 10.1016/j.arbr.2021.04.006] [Reference Citation Analysis]
|
| 3 |
da Costa LM, Bernardi FA, Michelin Sanches TL, Kritski A, Galliez RM, Alves D. Operational modeling for testing diagnostic tools impact on tuberculosis diagnostic cascade: A model design. Procedia Computer Science 2021;181:650-657. [DOI: 10.1016/j.procs.2021.01.214] [Reference Citation Analysis]
|
| 4 |
Seminario A, Anibarro L, Sabriá J, García-Clemente MM, Sánchez-Montalván A, Medina JF, Mir I, Penas A, Caminero JA, Pérez GJ, Altet N, Domínguez Á, Jiménez-Fuentes MÁ, Quirós S, Tabernero EM, Souza-Galvão ML, Sáez A, Caylà JA, García-García JM, Rodrigo T; Grupo de Trabajo del Programa Integrado de Investigación en Tuberculosis (PII-TB) de la Sociedad Española de Neumología y Cirugía Torácica (SEPAR). Study of the Diagnostic Delay of Tuberculosis in Spain. Arch Bronconeumol 2021;57:440-2. [PMID: 33158643 DOI: 10.1016/j.arbres.2020.09.003] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 5 |
Deo S, Singh S, Jha N, Arinaminpathy N, Dewan P. Predicting the impact of patient and private provider behavior on diagnostic delay for pulmonary tuberculosis patients in India: A simulation modeling study. PLoS Med 2020;17:e1003039. [PMID: 32407407 DOI: 10.1371/journal.pmed.1003039] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 6 |
Padmasawitri TIA, Frederix GW, Alisjahbana B, Klungel O, Hövels AM. Disparities in model-based cost-effectiveness analyses of tuberculosis diagnosis: A systematic review. PLoS One 2018;13:e0193293. [PMID: 29742106 DOI: 10.1371/journal.pone.0193293] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
|
| 7 |
Vinuesa V, Borrás R, Briones ML, Clari MÁ, Cresencio V, Giménez E, Muñoz C, Oltra R, Servera E, Scheelje T, Tornero C, Navarro D. Performance of a Highly Sensitive Mycobacterium tuberculosis Complex Real-Time PCR Assay for Diagnosis of Pulmonary Tuberculosis in a Low-Prevalence Setting: a Prospective Intervention Study. J Clin Microbiol 2018;56:e00116-18. [PMID: 29540457 DOI: 10.1128/JCM.00116-18] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 1.2] [Reference Citation Analysis]
|
| 8 |
Li J, Yip BHK, Leung C, Chung W, Kwok KO, Chan EYY, Yeoh E, Chung P. Screening for latent and active tuberculosis infection in the elderly at admission to residential care homes: A cost-effectiveness analysis in an intermediate disease burden area. PLoS One 2018;13:e0189531. [PMID: 29293514 DOI: 10.1371/journal.pone.0189531] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.4] [Reference Citation Analysis]
|
| 9 |
Cowan JF, Chandler AS, Kracen E, Park DR, Wallis CK, Liu E, Song C, Persing DH, Fang FC. Clinical Impact and Cost-effectiveness of Xpert MTB/RIF Testing in Hospitalized Patients With Presumptive Pulmonary Tuberculosis in the United States. Clin Infect Dis 2017;64:482-9. [PMID: 28172666 DOI: 10.1093/cid/ciw803] [Cited by in Crossref: 5] [Cited by in F6Publishing: 16] [Article Influence: 0.8] [Reference Citation Analysis]
|
| 10 |
Basybekov SZ, Bazarbayev MB, Yespembetov BA, Mussaeva A, Kanatbayev SG, Romashev KM, Dossanova AK, Yelekeyev TA, Akmatova EK, Syrym NS. Diagnostics of tuberculosis and differentiation of nonspecific tuberculin reactions in animals. Braz J Microbiol 2018;49:329-35. [PMID: 29153452 DOI: 10.1016/j.bjm.2017.07.004] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 11 |
Li J, Chung PH, Leung CLK, Nishikiori N, Chan EYY, Yeoh EK. The strategic framework of tuberculosis control and prevention in the elderly: a scoping review towards End TB targets. Infect Dis Poverty 2017;6:70. [PMID: 28569191 DOI: 10.1186/s40249-017-0284-4] [Cited by in Crossref: 23] [Cited by in F6Publishing: 25] [Article Influence: 3.8] [Reference Citation Analysis]
|
| 12 |
Yang R, Zhang H, Xiong Y, Gui X, Zhang Y, Deng L, Gao S, Luo M, Hou W, Guo D. Molecular diagnosis of central nervous system opportunistic infections and mortality in HIV-infected adults in Central China. AIDS Res Ther 2017;14:24. [PMID: 28469695 DOI: 10.1186/s12981-017-0150-2] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 2.5] [Reference Citation Analysis]
|
| 13 |
Pescarini JM, Rodrigues LC, Gomes MG, Waldman EA. Migration to middle-income countries and tuberculosis-global policies for global economies. Global Health 2017;13:15. [PMID: 28298223 DOI: 10.1186/s12992-017-0236-6] [Cited by in Crossref: 18] [Cited by in F6Publishing: 23] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 14 |
Drancourt M, Michel-Lepage A, Boyer S, Raoult D. The Point-of-Care Laboratory in Clinical Microbiology. Clin Microbiol Rev 2016;29:429-47. [PMID: 27029593 DOI: 10.1128/CMR.00090-15] [Cited by in Crossref: 111] [Cited by in F6Publishing: 112] [Article Influence: 15.9] [Reference Citation Analysis]
|
| 15 |
Houben RMGJ, Menzies NA, Sumner T, Huynh GH, Arinaminpathy N, Goldhaber-Fiebert JD, Lin HH, Wu CY, Mandal S, Pandey S, Suen SC, Bendavid E, Azman AS, Dowdy DW, Bacaër N, Rhines AS, Feldman MW, Handel A, Whalen CC, Chang ST, Wagner BG, Eckhoff PA, Trauer JM, Denholm JT, McBryde ES, Cohen T, Salomon JA, Pretorius C, Lalli M, Eaton JW, Boccia D, Hosseini M, Gomez GB, Sahu S, Daniels C, Ditiu L, Chin DP, Wang L, Chadha VK, Rade K, Dewan P, Hippner P, Charalambous S, Grant AD, Churchyard G, Pillay Y, Mametja LD, Kimerling ME, Vassall A, White RG. Feasibility of achieving the 2025 WHO global tuberculosis targets in South Africa, China, and India: a combined analysis of 11 mathematical models. Lancet Glob Health 2016;4:e806-15. [PMID: 27720688 DOI: 10.1016/S2214-109X(16)30199-1] [Cited by in Crossref: 101] [Cited by in F6Publishing: 110] [Article Influence: 14.4] [Reference Citation Analysis]
|
| 16 |
Datta S, Budhauliya R, Chatterjee S, Vanlalhmuaka, Veer V, Chakravarty R. Enhancement of PCR Detection Limit by Single-Tube Restriction Endonuclease-PCR (RE-PCR). Mol Diagn Ther 2016;20:297-305. [PMID: 26993322 DOI: 10.1007/s40291-016-0195-2] [Reference Citation Analysis]
|
| 17 |
Vassall A, Mangham-Jefferies L, Gomez GB, Pitt C, Foster N. Incorporating Demand and Supply Constraints into Economic Evaluations in Low-Income and Middle-Income Countries. Health Econ 2016;25 Suppl 1:95-115. [PMID: 26786617 DOI: 10.1002/hec.3306] [Cited by in Crossref: 29] [Cited by in F6Publishing: 33] [Article Influence: 4.1] [Reference Citation Analysis]
|
| 18 |
Arinaminpathy N, Dowdy D. Understanding the incremental value of novel diagnostic tests for tuberculosis. Nature 2015;528:S60-7. [DOI: 10.1038/nature16045] [Cited by in Crossref: 96] [Cited by in F6Publishing: 97] [Article Influence: 12.0] [Reference Citation Analysis]
|
| 19 |
Knight GM, Dharan NJ, Fox GJ, Stennis N, Zwerling A, Khurana R, Dowdy DW. Bridging the gap between evidence and policy for infectious diseases: How models can aid public health decision-making. Int J Infect Dis 2016;42:17-23. [PMID: 26546234 DOI: 10.1016/j.ijid.2015.10.024] [Cited by in Crossref: 44] [Cited by in F6Publishing: 47] [Article Influence: 5.5] [Reference Citation Analysis]
|
| 20 |
Myneedu VP, Singhal R, Khayyam KU, Sharma PP, Bhalla M, Behera D, Sarin R. First and second line drug resistance among treatment naïve pulmonary tuberculosis patients in a district under Revised National Tuberculosis Control Programme (RNTCP) in New Delhi. J Epidemiol Glob Health 2015;5:365-73. [PMID: 25944154 DOI: 10.1016/j.jegh.2015.04.002] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 1.1] [Reference Citation Analysis]
|
| 21 |
Huynh GH, Klein DJ, Chin DP, Wagner BG, Eckhoff PA, Liu R, Wang L. Tuberculosis control strategies to reach the 2035 global targets in China: the role of changing demographics and reactivation disease. BMC Med 2015;13:88. [PMID: 25896465 DOI: 10.1186/s12916-015-0341-4] [Cited by in Crossref: 51] [Cited by in F6Publishing: 47] [Article Influence: 6.4] [Reference Citation Analysis]
|
